Stephanie Siegmund
ORCID: 0000-0003-1848-2389Also affiliated with Harvard University, University of California, San Francisco, Columbia University Irving Medical Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy”.
Tyler Janovitz, Dora Dias-Santagata, Stephanie Siegmund, Valentina Nardi, Lori J. Wirth +12 more
Rashad Nawfal, John Canniff, Hunter Savignano, Ji-Heui Seo, Stephanie Siegmund +17 more
Cheri M. Hampton, Robert Langlois, Roberto Melero, Zachary J. Farino, Michael Calderon +39 more
Aarti E. Sharma, Stephanie Siegmund, Chrystalle Katte Carreon, Colin J.R. Stewart, Fabíola Medeiros +8 more
Alexander Neil, Stephanie Siegmund, Amir Dehghani, Azra H. Ligon, Ursula A. Matulonis +5 more